D K Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 5.35 Cr
as on 10-12-2024
- Paid Up Capital ₹ 2.50 M
as on 10-12-2024
- Company Age 35 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 86.12 Cr
as on 10-12-2024
- Satisfied Charges ₹ 66.78 Cr
as on 10-12-2024
- Revenue 28.98%
(FY 2023)
- Profit 45.60%
(FY 2023)
- Ebitda 30.02%
(FY 2023)
- Net Worth 27.20%
(FY 2023)
- Total Assets 4.89%
(FY 2023)
About D K Pharma Chem
The Corporate was formerly known as Bakshi Pharmamideates Pvt Ltd. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.35 Cr and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹86.12 Cr. The company has closed loans amounting to ₹66.78 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Bakshi, Ajit Behere, Ravinderkumar Varmani, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH1989PTC053428
- Company No.
053428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at D K Pharma Chem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Bakshi  | Managing Director | 19-Sep-1989 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ravindra Palkar | Director | 23-Dec-2021 | Current |
| Ajit Behere | Director | 01-Jul-2008 | Current |
| Ravinderkumar Varmani | Director | 01-Apr-2006 | Current |
| Karan Bakshi | Director | 11-Dec-2008 | Current |
Financial Performance of D K Pharma Chem.
D K Pharma Chem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.98% increase. The company also saw a substantial improvement in profitability, with a 45.6% increase in profit. The company's net worth Soared by an impressive increase of 27.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D K Pharma Chem?
In 2023, D K Pharma Chem had a promoter holding of 99.99% and a public holding of 0.01%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
D.K. Livkon Healthcare Private LimitedActive 10 years 9 monthsRakesh Bakshi and Karan Bakshi are mutual person
D.K. Pharma Tech Private LimitedActive 7 years 9 monthsRakesh Bakshi and Karan Bakshi are mutual person
- Eco Green Industries Private LimitedActive 24 years 10 months
Rakesh Bakshi and Karan Bakshi are mutual person
- D.K. Biopharma Private LimitedActive 6 years 5 months
Rakesh Bakshi, Ajit Behere and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Mar 2024 | ₹2.50 M | Open |
Tjsb Sahakari Bank Limited Creation Date: 09 Mar 2023 | ₹7.50 Cr | Open |
Hdfc Bank Limited Creation Date: 03 Dec 2020 | ₹1.26 M | Open |
How Many Employees Work at D K Pharma Chem?
D K Pharma Chem has a workforce of 143 employees as of Dec 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D K Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D K Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
